ACTRN12617000324314已完成3 期
A randomised, double blind, placebo controlled trial to assess the feasibility and acceptability of synbiotic supplementation in patients with chronic kidney disease
A/Prof Katrina Campbell0 个研究点目标入组 68 人开始时间: 2017年3月1日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •CKD stage III-IV: GFR stable between 15-60 ml/min (for the past 3 months),
- •Under the care of a nephrologist,
- •Able to provide informed consent
排除标准
- •- Previous clinically significant change in immunosuppressant dose within six months determined by the medical team
- •- Receiving/or have received radiation to the bowel or large bowel resection
- •- Medically diagnosed and active irritable bowel syndrome, active Crohn’s disease, ulcerative colitis
- •- Cirrhotic liver disease
- •- Received prebiotic, probiotic or anti-biotic therapy within 1 month of study commencement
- •- Unable to understand English
- •- Unable/unwilling to comply with follow-up
- •- Life expectancy limited due to pre-existing malignancy or other disease (<6 months)
- •- Likely to progress to end-stage treatment within 12 months as determined by the treating physician
- •- Pregnancy
- •- Severely malnourished (Subjective Global Assessment: C)
研究者
相似试验
进行中（未招募）
1 期
A randomised, double blind, placebo controlled trial to evaluate the safety, efficacy and pharmakokinetics of Pleconaril as an add on to AchEI/memantine for treatment of patients with Alzheimer’s diseaseAlzheimer's diseaseEUCTR2017-004125-32-CZApodemus Aktiebolag120
进行中（未招募）
1 期
A randomised, double blind, placebo controlled trial to evaluate the safety, efficacy and pharmakokinetics of Pleconaril as an add on to AchEI/memantine for treatment of patients with Alzheimer’s diseaseMedDRA version: 20.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 100000004852Alzheimer's diseaseEUCTR2017-004125-32-PLApodemus Aktiebolag120
已完成
3 期
A topical cold sore treatment containing St John's Wort, Calendula and CopperHerpes Simplex LabialisSkin - Dermatological conditionsAlternative and Complementary Medicine - Herbal remediesInfection - Other infectious diseasesACTRN12618000890235Western Sydney University272
已完成
4 期
Antibiotics for bronchiectasis exacerbations in children - The Bronchiectasis Exacerbation Study (Study 1).BronchiectasisRespiratory - Other respiratory disorders / diseasesACTRN12612000011886Qld Children's Medical Research Institute189
进行中（未招募）
不适用
A randomised, double blind, placebo controlled trial of doxycycline in lymphangioleiomyomatosis. - Doxycycline in LAMymphangioleiomyomatosisMedDRA version: 9.1Level: LLTClassification code 10049459Term: LymphangioleiomyomatosisMedDRA version: 9.1Level: PTClassification code 10049459Term: LymphangioleiomyomatosisEUCTR2007-003745-32-GBniversity of Nottingham